Novel agents in CML therapy: tyrosine kinase inhibitors and beyond

JV Melo, C Chuah - ASH Education Program Book, 2008 - ashpublications.org
The emergence of resistance to imatinib has become a significant problem despite the
remarkable clinical results achieved with this tyrosine kinase inhibitor in the treatment of …
被引用次数：77 相关文章
[PDF] psu.edu

[PDF][PDF] Novel Agents in CML Therapy: Tyrosine Kinase Inhibitors and Beyond

JV Melo, C Chuah - Hematology, 2008 - Citeseer
The emergence of resistance to imatinib has become a significant problem despite the
remarkable clinical results achieved with this tyrosine kinase inhibitor in the treatment of …

Novel Agents in CML Therapy: Tyrosine Kinase Inhibitors and Beyond

JV Melo, C Chuah - Hematology, 2008 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The emergence of resistance to imatinib has
become a significant problem despite the remarkable clinical results achieved with this …
[PDF] archive.org

[PDF][PDF] Novel Agents in CML Therapy: Tyrosine Kinase Inhibitors and Beyond

JV Melo, C Chuah - Hematology, 2008 - scholar.archive.org
The emergence of resistance to imatinib has become a significant problem despite the
remarkable clinical results achieved with this tyrosine kinase inhibitor in the treatment of …

Novel agents in CML therapy: tyrosine kinase inhibitors and beyond.

JV Melo, C Chuah - Hematology. American Society of Hematology …, 2008 - europepmc.org
The emergence of resistance to imatinib has become a significant problem despite the
remarkable clinical results achieved with this tyrosine kinase inhibitor in the treatment of …

Novel agents in CML therapy: tyrosine kinase inhibitors and beyond

JV Melo, C Chuah - Hematology. American Society of …, 2008 - pubmed.ncbi.nlm.nih.gov
The emergence of resistance to imatinib has become a significant problem despite the
remarkable clinical results achieved with this tyrosine kinase inhibitor in the treatment of …

[引用][C] Novel Agents in CML Therapy: Tyrosine Kinase Inhibitors and Beyond

M JV - Hematology Am Soc Hematol Educ Program, 2008 - cir.nii.ac.jp
Novel Agents in CML Therapy : Tyrosine Kinase Inhibitors and Beyond | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …